

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.73664521 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.32919812 |
| 3 | NADH metabolic process (GO:0006734) | 6.81496556 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.59854852 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 6.59854852 |
| 6 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.05702894 |
| 7 | * respiratory electron transport chain (GO:0022904) | 6.03902240 |
| 8 | oxidative phosphorylation (GO:0006119) | 5.87695994 |
| 9 | * electron transport chain (GO:0022900) | 5.87265985 |
| 10 | oxaloacetate metabolic process (GO:0006107) | 5.53699492 |
| 11 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.51440707 |
| 12 | succinate metabolic process (GO:0006105) | 5.42681681 |
| 13 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.24111937 |
| 14 | regulation of cofactor metabolic process (GO:0051193) | 4.93325013 |
| 15 | regulation of coenzyme metabolic process (GO:0051196) | 4.93325013 |
| 16 | lysine metabolic process (GO:0006553) | 4.85675286 |
| 17 | lysine catabolic process (GO:0006554) | 4.85675286 |
| 18 | proteasome assembly (GO:0043248) | 4.63576652 |
| 19 | aspartate family amino acid catabolic process (GO:0009068) | 4.59496342 |
| 20 | 2-oxoglutarate metabolic process (GO:0006103) | 4.55457365 |
| 21 | respiratory chain complex IV assembly (GO:0008535) | 4.46836720 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.40163176 |
| 23 | ATP biosynthetic process (GO:0006754) | 4.28293586 |
| 24 | fatty acid beta-oxidation (GO:0006635) | 4.13894481 |
| 25 | cytochrome complex assembly (GO:0017004) | 4.13390998 |
| 26 | sarcomere organization (GO:0045214) | 4.04632243 |
| 27 | aerobic respiration (GO:0009060) | 4.02066498 |
| 28 | protein complex biogenesis (GO:0070271) | 3.94380862 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 3.93871599 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.90658477 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.90658477 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 3.90658477 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.87555388 |
| 34 | branched-chain amino acid metabolic process (GO:0009081) | 3.87162799 |
| 35 | regulation of sulfur metabolic process (GO:0042762) | 3.86785219 |
| 36 | carnitine shuttle (GO:0006853) | 3.86694888 |
| 37 | pseudouridine synthesis (GO:0001522) | 3.79889764 |
| 38 | regulation of mitochondrial translation (GO:0070129) | 3.77798769 |
| 39 | ubiquinone biosynthetic process (GO:0006744) | 3.76207224 |
| 40 | quinone biosynthetic process (GO:1901663) | 3.76207224 |
| 41 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.73953514 |
| 42 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.69879792 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 3.67802689 |
| 44 | fatty acid catabolic process (GO:0009062) | 3.66648752 |
| 45 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.65460930 |
| 46 | DNA deamination (GO:0045006) | 3.62459829 |
| 47 | acetyl-CoA metabolic process (GO:0006084) | 3.59885033 |
| 48 | actin-myosin filament sliding (GO:0033275) | 3.59781813 |
| 49 | muscle filament sliding (GO:0030049) | 3.59781813 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.59517083 |
| 51 | kynurenine metabolic process (GO:0070189) | 3.56580087 |
| 52 | fatty acid oxidation (GO:0019395) | 3.55626528 |
| 53 | short-chain fatty acid metabolic process (GO:0046459) | 3.52793808 |
| 54 | cardiac myofibril assembly (GO:0055003) | 3.52685540 |
| 55 | cellular respiration (GO:0045333) | 3.51447364 |
| 56 | cullin deneddylation (GO:0010388) | 3.51201014 |
| 57 | lipid oxidation (GO:0034440) | 3.49368776 |
| 58 | biotin metabolic process (GO:0006768) | 3.48622610 |
| 59 | ketone body metabolic process (GO:1902224) | 3.47541000 |
| 60 | inner mitochondrial membrane organization (GO:0007007) | 3.44525500 |
| 61 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.44429058 |
| 62 | hydrogen ion transmembrane transport (GO:1902600) | 3.39025917 |
| 63 | signal peptide processing (GO:0006465) | 3.38584944 |
| 64 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.37568596 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 3.37209397 |
| 66 | glyoxylate metabolic process (GO:0046487) | 3.36827588 |
| 67 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.36611176 |
| 68 | termination of RNA polymerase III transcription (GO:0006386) | 3.36611176 |
| 69 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.35937368 |
| 70 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.35937368 |
| 71 | NAD metabolic process (GO:0019674) | 3.34910168 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 3.34823205 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 3.34823205 |
| 74 | tryptophan catabolic process (GO:0006569) | 3.34823205 |
| 75 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.33537750 |
| 76 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.33474203 |
| 77 | rRNA modification (GO:0000154) | 3.32000974 |
| 78 | ubiquinone metabolic process (GO:0006743) | 3.31021542 |
| 79 | regulation of oxidative phosphorylation (GO:0002082) | 3.29537482 |
| 80 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.29163248 |
| 81 | L-phenylalanine metabolic process (GO:0006558) | 3.28702809 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.28702809 |
| 83 | heart contraction (GO:0060047) | 3.27089682 |
| 84 | heart process (GO:0003015) | 3.27089682 |
| 85 | gluconeogenesis (GO:0006094) | 3.26549696 |
| 86 | peptidyl-histidine modification (GO:0018202) | 3.26537820 |
| 87 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.26398500 |
| 88 | monocarboxylic acid catabolic process (GO:0072329) | 3.25026657 |
| 89 | cardiac muscle contraction (GO:0060048) | 3.23928409 |
| 90 | protein deneddylation (GO:0000338) | 3.23370563 |
| 91 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.22430137 |
| 92 | carnitine metabolic process (GO:0009437) | 3.21587250 |
| 93 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.20065268 |
| 94 | myofibril assembly (GO:0030239) | 3.20040126 |
| 95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.17953226 |
| 96 | hexose biosynthetic process (GO:0019319) | 3.16886470 |
| 97 | amino-acid betaine metabolic process (GO:0006577) | 3.16815480 |
| 98 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.16753791 |
| 99 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.15376506 |
| 100 | valine metabolic process (GO:0006573) | 3.15331708 |
| 101 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.12025385 |
| 102 | L-methionine salvage (GO:0071267) | 3.11510768 |
| 103 | L-methionine biosynthetic process (GO:0071265) | 3.11510768 |
| 104 | amino acid salvage (GO:0043102) | 3.11510768 |
| 105 | DNA double-strand break processing (GO:0000729) | 3.11378354 |
| 106 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.10734678 |
| 107 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.10734678 |
| 108 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.10734678 |
| 109 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.10147405 |
| 110 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.10127178 |
| 111 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.07498506 |
| 112 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.07498506 |
| 113 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.07308465 |
| 114 | L-phenylalanine catabolic process (GO:0006559) | 3.07308465 |
| 115 | indolalkylamine metabolic process (GO:0006586) | 3.07077634 |
| 116 | mitochondrial transport (GO:0006839) | 3.06582739 |
| 117 | mannosylation (GO:0097502) | 3.03510809 |
| 118 | tryptophan metabolic process (GO:0006568) | 2.99610421 |
| 119 | protein targeting to mitochondrion (GO:0006626) | 2.99420332 |
| 120 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.98547815 |
| 121 | negative regulation of ligase activity (GO:0051352) | 2.98547815 |
| 122 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.98476499 |
| 123 | regulation of cellular respiration (GO:0043457) | 2.97634473 |
| 124 | proton transport (GO:0015992) | 2.97250057 |
| 125 | carnitine transmembrane transport (GO:1902603) | 2.96710396 |
| 126 | chaperone-mediated protein transport (GO:0072321) | 2.96349105 |
| 127 | monosaccharide biosynthetic process (GO:0046364) | 2.96022706 |
| 128 | hydrogen transport (GO:0006818) | 2.95330563 |
| 129 | carnitine transport (GO:0015879) | 2.94416519 |
| 130 | amino-acid betaine transport (GO:0015838) | 2.94416519 |
| 131 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94217658 |
| 132 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94217658 |
| 133 | regulation of fatty acid oxidation (GO:0046320) | 2.94136843 |
| 134 | regulation of skeletal muscle contraction (GO:0014819) | 2.93087565 |
| 135 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.92976924 |
| 136 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.92976924 |
| 137 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.92102211 |
| 138 | methionine biosynthetic process (GO:0009086) | 2.91840039 |
| 139 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91343208 |
| 140 | protein neddylation (GO:0045116) | 2.89913145 |
| 141 | cardiac muscle cell development (GO:0055013) | 2.89883591 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.87623911 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.87623911 |
| 144 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.87339326 |
| 145 | regulation of relaxation of muscle (GO:1901077) | 2.86930678 |
| 146 | aspartate family amino acid metabolic process (GO:0009066) | 2.86383271 |
| 147 | maturation of 5.8S rRNA (GO:0000460) | 2.86350875 |
| 148 | intracellular protein transmembrane import (GO:0044743) | 2.83546813 |
| 149 | rRNA methylation (GO:0031167) | 2.83308564 |
| 150 | tRNA processing (GO:0008033) | 2.82046470 |
| 151 | protein localization to mitochondrion (GO:0070585) | 2.78377477 |
| 152 | mitochondrial RNA metabolic process (GO:0000959) | 2.77718663 |
| 153 | establishment of protein localization to mitochondrion (GO:0072655) | 2.75533399 |
| 154 | protein K6-linked ubiquitination (GO:0085020) | 2.73214954 |
| 155 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69030503 |
| 156 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.69001566 |
| 157 | aldehyde catabolic process (GO:0046185) | 2.66181481 |
| 158 | methionine metabolic process (GO:0006555) | 2.64799221 |
| 159 | response to pheromone (GO:0019236) | 2.61296683 |
| 160 | positive regulation of ligase activity (GO:0051351) | 2.57563977 |
| 161 | recombinational repair (GO:0000725) | 2.56586883 |
| 162 | double-strand break repair via homologous recombination (GO:0000724) | 2.56050607 |
| 163 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.54123043 |
| 164 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.54003700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.52870523 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.08529551 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.69798971 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.10343057 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.71895762 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.62994316 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.42407962 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.32099024 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.30824328 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.22184372 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.18423740 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.16056729 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.03963852 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89043410 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.86529822 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83161679 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.76131053 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.69104344 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63908881 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.60216565 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.54835227 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.47328360 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41753749 |
| 24 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.31527619 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.28250005 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.25129035 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25045812 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16650169 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15691685 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.09687891 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05894604 |
| 32 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04971241 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01781098 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.96286520 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94616707 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.92471093 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91041439 |
| 38 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.79453183 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75068078 |
| 40 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.74380918 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74134136 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73774710 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73665583 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.72082569 |
| 45 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.71206281 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67643196 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.63661998 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62962338 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59891594 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56125213 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54455258 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54072217 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53464699 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52583483 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51613266 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49444901 |
| 57 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48765794 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44751154 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.43292664 |
| 60 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.42892554 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42695749 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42081795 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39073863 |
| 64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39043460 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38151317 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37734746 |
| 67 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36826111 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34244683 |
| 69 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33899151 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33196818 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26447997 |
| 72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26447997 |
| 73 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26111961 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25869417 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25798999 |
| 76 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.25147673 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25067070 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24752780 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.24532711 |
| 80 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24007370 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21150044 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21150044 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20118989 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19430854 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18453649 |
| 86 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18323390 |
| 87 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18323390 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16220444 |
| 89 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15180876 |
| 90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15003120 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14644761 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14572297 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13517047 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13280560 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12596924 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11741759 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11457621 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10628931 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10293120 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08090096 |
| 101 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07896077 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06007965 |
| 103 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02802821 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02557100 |
| 105 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01039161 |
| 106 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00908052 |
| 107 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00013895 |
| 108 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99958025 |
| 109 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98266228 |
| 110 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95573419 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95548559 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94735090 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94647271 |
| 114 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94571721 |
| 115 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93764638 |
| 116 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.93631908 |
| 117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93376077 |
| 118 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93340819 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92466667 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92292565 |
| 121 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92028605 |
| 122 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91074358 |
| 123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90953404 |
| 124 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.90861928 |
| 125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90516812 |
| 126 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90349964 |
| 127 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89892367 |
| 128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89672607 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89650540 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89480070 |
| 131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89377258 |
| 132 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.89166834 |
| 133 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88664824 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87975480 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87675008 |
| 136 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86031905 |
| 137 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85436116 |
| 138 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85105470 |
| 139 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85059034 |
| 140 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84859766 |
| 141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82933044 |
| 142 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81402377 |
| 143 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81312283 |
| 144 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.80215890 |
| 145 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79915869 |
| 146 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.79726624 |
| 147 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77489712 |
| 148 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.76858574 |
| 149 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76856009 |
| 150 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.76616347 |
| 151 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76034411 |
| 152 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.73680230 |
| 153 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.73355254 |
| 154 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.73298905 |
| 155 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.73295055 |
| 156 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72437089 |
| 157 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71193143 |
| 158 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70431523 |
| 159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70431523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.25980933 |
| 2 | MP0003646_muscle_fatigue | 4.98344359 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.95834193 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.87965889 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.65552019 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 3.55023521 |
| 7 | MP0000751_myopathy | 3.52377609 |
| 8 | MP0000372_irregular_coat_pigmentation | 3.43836107 |
| 9 | MP0005360_urolithiasis | 3.34050238 |
| 10 | MP0004036_abnormal_muscle_relaxation | 3.21531536 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.21365598 |
| 12 | MP0000749_muscle_degeneration | 3.14666832 |
| 13 | MP0005330_cardiomyopathy | 3.07057561 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.94544030 |
| 15 | MP0006035_abnormal_mitochondrial_morpho | 2.51312725 |
| 16 | MP0008058_abnormal_DNA_repair | 2.48560853 |
| 17 | MP0008057_abnormal_DNA_replication | 2.48237206 |
| 18 | MP0004130_abnormal_muscle_cell | 2.37466229 |
| 19 | MP0005365_abnormal_bile_salt | 2.37281050 |
| 20 | MP0005332_abnormal_amino_acid | 2.29887218 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26174207 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.22393134 |
| 23 | MP0002102_abnormal_ear_morphology | 2.15547177 |
| 24 | MP0008775_abnormal_heart_ventricle | 2.14441102 |
| 25 | MP0005620_abnormal_muscle_contractility | 2.04179755 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.99284089 |
| 27 | MP0002269_muscular_atrophy | 1.98670668 |
| 28 | MP0010094_abnormal_chromosome_stability | 1.97815598 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.94906735 |
| 30 | MP0003195_calcinosis | 1.93482583 |
| 31 | MP0003137_abnormal_impulse_conducting | 1.91286649 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.88646568 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 1.88646568 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.83461997 |
| 35 | MP0004484_altered_response_of | 1.82117153 |
| 36 | MP0003186_abnormal_redox_activity | 1.78670485 |
| 37 | MP0004043_abnormal_pH_regulation | 1.77904365 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.77738697 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.76265765 |
| 40 | MP0006138_congestive_heart_failure | 1.70380560 |
| 41 | MP0001764_abnormal_homeostasis | 1.69629586 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.68637486 |
| 43 | MP0002938_white_spotting | 1.63392169 |
| 44 | MP0000747_muscle_weakness | 1.61582130 |
| 45 | MP0004147_increased_porphyrin_level | 1.61254544 |
| 46 | MP0005670_abnormal_white_adipose | 1.61150005 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.60789762 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.60142033 |
| 49 | MP0002106_abnormal_muscle_physiology | 1.59729711 |
| 50 | MP0005253_abnormal_eye_physiology | 1.56879596 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.53152109 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.47390196 |
| 53 | MP0005266_abnormal_metabolism | 1.47045352 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.46941060 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.46432218 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.46169300 |
| 57 | MP0003786_premature_aging | 1.42138361 |
| 58 | MP0010630_abnormal_cardiac_muscle | 1.42101943 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.39625216 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.39561245 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.34114689 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33953893 |
| 63 | MP0005408_hypopigmentation | 1.33513555 |
| 64 | MP0004085_abnormal_heartbeat | 1.32971630 |
| 65 | MP0004233_abnormal_muscle_weight | 1.32801062 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.32438819 |
| 67 | MP0009840_abnormal_foam_cell | 1.32414679 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.31072316 |
| 69 | MP0005083_abnormal_biliary_tract | 1.30339462 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.29169053 |
| 71 | MP0005369_muscle_phenotype | 1.28067828 |
| 72 | MP0009697_abnormal_copulation | 1.26476156 |
| 73 | MP0003136_yellow_coat_color | 1.25015666 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 1.17831034 |
| 75 | MP0005410_abnormal_fertilization | 1.17634530 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 1.17141633 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.15788553 |
| 78 | MP0005535_abnormal_body_temperature | 1.11224216 |
| 79 | MP0002234_abnormal_pharynx_morphology | 1.10016522 |
| 80 | MP0002127_abnormal_cardiovascular_syste | 1.09409821 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.09336555 |
| 82 | MP0009745_abnormal_behavioral_response | 1.07515237 |
| 83 | MP0001986_abnormal_taste_sensitivity | 1.06899728 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.05953696 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.05168014 |
| 86 | MP0002272_abnormal_nervous_system | 1.04080838 |
| 87 | MP0002971_abnormal_brown_adipose | 1.03584028 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.03161258 |
| 89 | MP0002095_abnormal_skin_pigmentation | 1.02522597 |
| 90 | MP0001485_abnormal_pinna_reflex | 1.02480279 |
| 91 | MP0000427_abnormal_hair_cycle | 1.01823526 |
| 92 | MP0000230_abnormal_systemic_arterial | 1.01475611 |
| 93 | MP0001529_abnormal_vocalization | 0.98845235 |
| 94 | MP0002090_abnormal_vision | 0.97352316 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.96978543 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.94937876 |
| 97 | MP0003252_abnormal_bile_duct | 0.94592142 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.93371900 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.91968542 |
| 100 | MP0001756_abnormal_urination | 0.90719735 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.89789458 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.89497161 |
| 103 | MP0003077_abnormal_cell_cycle | 0.89285091 |
| 104 | MP0000609_abnormal_liver_physiology | 0.89243799 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.88908088 |
| 106 | MP0005165_increased_susceptibility_to | 0.88798105 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.88364269 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.86772152 |
| 109 | MP0003111_abnormal_nucleus_morphology | 0.85397403 |
| 110 | MP0002163_abnormal_gland_morphology | 0.85044687 |
| 111 | MP0002822_catalepsy | 0.83298425 |
| 112 | MP0002160_abnormal_reproductive_system | 0.82328722 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.82181262 |
| 114 | MP0001984_abnormal_olfaction | 0.81976893 |
| 115 | MP0000358_abnormal_cell_content/ | 0.78301394 |
| 116 | MP0005395_other_phenotype | 0.77814360 |
| 117 | MP0000343_altered_response_to | 0.77702544 |
| 118 | MP0001929_abnormal_gametogenesis | 0.77528193 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.77161908 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.76878889 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.75996714 |
| 122 | MP0005451_abnormal_body_composition | 0.75715813 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.71317779 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.69607402 |
| 125 | MP0008004_abnormal_stomach_pH | 0.69187603 |
| 126 | MP0002064_seizures | 0.68994650 |
| 127 | MP0003698_abnormal_male_reproductive | 0.68353162 |
| 128 | MP0002210_abnormal_sex_determination | 0.68002891 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.67800561 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.67437681 |
| 131 | MP0003718_maternal_effect | 0.66282142 |
| 132 | MP0008872_abnormal_physiological_respon | 0.65468579 |
| 133 | MP0004142_abnormal_muscle_tone | 0.62330122 |
| 134 | MP0002736_abnormal_nociception_after | 0.61668019 |
| 135 | MP0003828_pulmonary_edema | 0.61488549 |
| 136 | MP0001661_extended_life_span | 0.57056171 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.55312649 |
| 138 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54852896 |
| 139 | MP0003880_abnormal_central_pattern | 0.54653568 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.54568838 |
| 141 | MP0009046_muscle_twitch | 0.52337890 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.51221637 |
| 143 | MP0004924_abnormal_behavior | 0.51221637 |
| 144 | MP0003011_delayed_dark_adaptation | 0.50857324 |
| 145 | MP0001905_abnormal_dopamine_level | 0.49511955 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.48284736 |
| 147 | MP0000598_abnormal_liver_morphology | 0.48213445 |
| 148 | MP0005334_abnormal_fat_pad | 0.48084674 |
| 149 | MP0009642_abnormal_blood_homeostasis | 0.47739502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.51773163 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.48555858 |
| 3 | Acute encephalopathy (HP:0006846) | 5.16639406 |
| 4 | * Hepatic necrosis (HP:0002605) | 5.01582960 |
| 5 | * Mitochondrial inheritance (HP:0001427) | 4.71074834 |
| 6 | * Hepatocellular necrosis (HP:0001404) | 4.69746190 |
| 7 | * Increased CSF lactate (HP:0002490) | 4.55611988 |
| 8 | Cerebral edema (HP:0002181) | 4.51846314 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.51646098 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.43298519 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.43298519 |
| 12 | Myoglobinuria (HP:0002913) | 4.22268599 |
| 13 | Sudden death (HP:0001699) | 3.96412908 |
| 14 | * Lactic acidosis (HP:0003128) | 3.92940264 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 3.87705357 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.85641056 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.85615981 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77368164 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.65450061 |
| 20 | Hyperglycinuria (HP:0003108) | 3.65409439 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 3.64507741 |
| 22 | Palpitations (HP:0001962) | 3.64407867 |
| 23 | Abnormality of alanine metabolism (HP:0010916) | 3.63088643 |
| 24 | Hyperalaninemia (HP:0003348) | 3.63088643 |
| 25 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.63088643 |
| 26 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.57604650 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 3.57604650 |
| 28 | Ketoacidosis (HP:0001993) | 3.54573904 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 3.47340017 |
| 30 | Exercise intolerance (HP:0003546) | 3.43698218 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41626146 |
| 32 | Hyperammonemia (HP:0001987) | 3.41509006 |
| 33 | * Respiratory failure (HP:0002878) | 3.41040475 |
| 34 | Lethargy (HP:0001254) | 3.36487397 |
| 35 | * Increased serum lactate (HP:0002151) | 3.32954250 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.31766988 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.30595341 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.28567307 |
| 39 | Pancreatic cysts (HP:0001737) | 3.25846559 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.25660259 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.25660259 |
| 42 | Ketosis (HP:0001946) | 3.24465188 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 3.22512235 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.22512235 |
| 45 | Pheochromocytoma (HP:0002666) | 3.15705358 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 3.09713909 |
| 47 | Nemaline bodies (HP:0003798) | 3.09073368 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 3.06839333 |
| 49 | Birth length less than 3rd percentile (HP:0003561) | 3.06830723 |
| 50 | Hyperglycinemia (HP:0002154) | 3.02140183 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.94157394 |
| 52 | Ragged-red muscle fibers (HP:0003200) | 2.92508632 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.86544884 |
| 54 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.85740191 |
| 55 | * CNS demyelination (HP:0007305) | 2.84082350 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.82273704 |
| 57 | 3-Methylglutaconic aciduria (HP:0003535) | 2.81063679 |
| 58 | Lipoatrophy (HP:0100578) | 2.78537394 |
| 59 | Conjunctival hamartoma (HP:0100780) | 2.77964419 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.75996167 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74472244 |
| 62 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.69385031 |
| 63 | Metabolic acidosis (HP:0001942) | 2.68939522 |
| 64 | Atrial fibrillation (HP:0005110) | 2.66919303 |
| 65 | Muscle fiber splitting (HP:0003555) | 2.63639745 |
| 66 | Abnormality of the calf musculature (HP:0001430) | 2.62504574 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.61711249 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.59873768 |
| 69 | Leukodystrophy (HP:0002415) | 2.59046473 |
| 70 | Vomiting (HP:0002013) | 2.54890889 |
| 71 | Gout (HP:0001997) | 2.54614316 |
| 72 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.53497106 |
| 73 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.53497106 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.53497106 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.53497106 |
| 76 | Syncope (HP:0001279) | 2.52578231 |
| 77 | Congenital stationary night blindness (HP:0007642) | 2.51600938 |
| 78 | Nausea (HP:0002018) | 2.50643107 |
| 79 | Supraventricular tachycardia (HP:0004755) | 2.46904413 |
| 80 | Optic disc pallor (HP:0000543) | 2.46372657 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.45815094 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 2.45815094 |
| 83 | Dilated cardiomyopathy (HP:0001644) | 2.45664932 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.44768108 |
| 85 | Glycosuria (HP:0003076) | 2.44768108 |
| 86 | Primary atrial arrhythmia (HP:0001692) | 2.44268566 |
| 87 | Neoplasm of the adrenal gland (HP:0100631) | 2.43874421 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.43623270 |
| 89 | Neoplasm of head and neck (HP:0012288) | 2.39239186 |
| 90 | Esophageal neoplasm (HP:0100751) | 2.39239186 |
| 91 | Supraventricular arrhythmia (HP:0005115) | 2.38755161 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 2.35483392 |
| 93 | Abnormality of the renal cortex (HP:0011035) | 2.32832541 |
| 94 | True hermaphroditism (HP:0010459) | 2.32107111 |
| 95 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26921761 |
| 96 | Right ventricular cardiomyopathy (HP:0011663) | 2.26252053 |
| 97 | Large for gestational age (HP:0001520) | 2.25894513 |
| 98 | Muscle stiffness (HP:0003552) | 2.24305464 |
| 99 | Cholelithiasis (HP:0001081) | 2.20822448 |
| 100 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18526248 |
| 101 | Respiratory difficulties (HP:0002880) | 2.17694096 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.15548643 |
| 103 | Ventricular fibrillation (HP:0001663) | 2.15417140 |
| 104 | Hypobetalipoproteinemia (HP:0003563) | 2.14960114 |
| 105 | Myotonia (HP:0002486) | 2.14630498 |
| 106 | Ventricular arrhythmia (HP:0004308) | 2.12000974 |
| 107 | Methylmalonic acidemia (HP:0002912) | 2.11605400 |
| 108 | * Emotional lability (HP:0000712) | 2.11072892 |
| 109 | Hyperventilation (HP:0002883) | 2.09598633 |
| 110 | Renal cortical cysts (HP:0000803) | 2.08895505 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.07629209 |
| 112 | Congenital, generalized hypertrichosis (HP:0004540) | 2.06536986 |
| 113 | Hyporeflexia of lower limbs (HP:0002600) | 2.06278593 |
| 114 | Nephronophthisis (HP:0000090) | 2.04986169 |
| 115 | Hypolipoproteinemia (HP:0010981) | 2.02759268 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 2.01453492 |
| 117 | Hyperuricemia (HP:0002149) | 2.00443914 |
| 118 | Increased purine levels (HP:0004368) | 2.00443914 |
| 119 | Inability to walk (HP:0002540) | 2.00442581 |
| 120 | Athetosis (HP:0002305) | 1.98630758 |
| 121 | Bundle branch block (HP:0011710) | 1.97944290 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 1.97396322 |
| 123 | Prolonged QT interval (HP:0001657) | 1.97322529 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 1.96882866 |
| 125 | * Gliosis (HP:0002171) | 1.95494259 |
| 126 | Exertional dyspnea (HP:0002875) | 1.93331456 |
| 127 | Progressive inability to walk (HP:0002505) | 1.90250628 |
| 128 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.90247546 |
| 129 | Medial flaring of the eyebrow (HP:0010747) | 1.89144093 |
| 130 | X-linked dominant inheritance (HP:0001423) | 1.86027930 |
| 131 | Microvesicular hepatic steatosis (HP:0001414) | 1.85643666 |
| 132 | Attenuation of retinal blood vessels (HP:0007843) | 1.83572926 |
| 133 | Abnormality of the pons (HP:0007361) | 1.81378371 |
| 134 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81042085 |
| 135 | Sclerocornea (HP:0000647) | 1.80376279 |
| 136 | Hypoplasia of the pons (HP:0012110) | 1.79799022 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78673231 |
| 138 | Type II lissencephaly (HP:0007260) | 1.77130457 |
| 139 | Hypoplasia of the fovea (HP:0007750) | 1.76636175 |
| 140 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76636175 |
| 141 | Abnormality of the renal medulla (HP:0100957) | 1.76294834 |
| 142 | Hypothermia (HP:0002045) | 1.75990363 |
| 143 | Abnormality of methionine metabolism (HP:0010901) | 1.75899923 |
| 144 | Opisthotonus (HP:0002179) | 1.73632972 |
| 145 | Abnormality of renal resorption (HP:0011038) | 1.72303550 |
| 146 | Broad-based gait (HP:0002136) | 1.69577547 |
| 147 | Pendular nystagmus (HP:0012043) | 1.68134130 |
| 148 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.68122400 |
| 149 | Amniotic constriction ring (HP:0009775) | 1.67674833 |
| 150 | Abnormality of placental membranes (HP:0011409) | 1.67674833 |
| 151 | Abnormality of macular pigmentation (HP:0008002) | 1.65297295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 4.89050300 |
| 2 | PDK3 | 4.89050300 |
| 3 | BCKDK | 4.83072385 |
| 4 | FRK | 4.75751269 |
| 5 | NEK1 | 3.85918150 |
| 6 | OBSCN | 3.48156640 |
| 7 | PDK2 | 3.25376674 |
| 8 | MYLK | 3.22241925 |
| 9 | BMPR1B | 3.13756480 |
| 10 | VRK2 | 2.92754487 |
| 11 | ACVR1B | 2.91365548 |
| 12 | EIF2AK1 | 2.73269834 |
| 13 | BUB1 | 2.68590609 |
| 14 | NME1 | 2.57317024 |
| 15 | TTN | 2.56821761 |
| 16 | LMTK2 | 2.41468805 |
| 17 | NUAK1 | 2.28285128 |
| 18 | PHKG2 | 2.16653288 |
| 19 | PHKG1 | 2.16653288 |
| 20 | TRIM28 | 2.02771463 |
| 21 | STK16 | 1.91200678 |
| 22 | STK38L | 1.84480718 |
| 23 | MAP4K2 | 1.81572720 |
| 24 | PINK1 | 1.79653229 |
| 25 | ADRBK2 | 1.76616953 |
| 26 | TSSK6 | 1.76444109 |
| 27 | NME2 | 1.62564647 |
| 28 | MAP3K12 | 1.62285798 |
| 29 | GRK1 | 1.51092573 |
| 30 | STK24 | 1.48651174 |
| 31 | SRPK1 | 1.46476786 |
| 32 | ZAK | 1.34250858 |
| 33 | CCNB1 | 1.33945182 |
| 34 | WNK4 | 1.30549598 |
| 35 | MKNK2 | 1.25123497 |
| 36 | EIF2AK3 | 1.16966539 |
| 37 | PKN2 | 1.15061128 |
| 38 | WEE1 | 1.15031676 |
| 39 | OXSR1 | 1.10887433 |
| 40 | PIK3CA | 1.09773954 |
| 41 | CASK | 1.06273827 |
| 42 | ILK | 1.03465160 |
| 43 | CDC7 | 0.97688329 |
| 44 | TGFBR1 | 0.96711779 |
| 45 | DAPK3 | 0.95769022 |
| 46 | TLK1 | 0.94413910 |
| 47 | CDK19 | 0.92395750 |
| 48 | GRK7 | 0.88637818 |
| 49 | KDR | 0.87654380 |
| 50 | NEK9 | 0.87533434 |
| 51 | TIE1 | 0.83559491 |
| 52 | CAMK2D | 0.81948845 |
| 53 | MAP2K4 | 0.81891139 |
| 54 | ERBB3 | 0.81679980 |
| 55 | LIMK1 | 0.81212122 |
| 56 | CSNK1G1 | 0.80234309 |
| 57 | PLK2 | 0.80092707 |
| 58 | CSNK1G3 | 0.78882453 |
| 59 | MUSK | 0.78482560 |
| 60 | TRIB3 | 0.77674651 |
| 61 | CDK8 | 0.77590471 |
| 62 | CAMK2G | 0.76690326 |
| 63 | TAF1 | 0.76567039 |
| 64 | FLT3 | 0.75266074 |
| 65 | AKT3 | 0.73948471 |
| 66 | DAPK1 | 0.70420688 |
| 67 | BRSK2 | 0.69928749 |
| 68 | MAP3K4 | 0.69786104 |
| 69 | MAP3K11 | 0.69120470 |
| 70 | TNIK | 0.69023979 |
| 71 | MAP2K7 | 0.67723103 |
| 72 | CSNK1A1L | 0.67640441 |
| 73 | MKNK1 | 0.66454260 |
| 74 | BRAF | 0.66022094 |
| 75 | MAPK13 | 0.64337099 |
| 76 | MAPK12 | 0.63724256 |
| 77 | MAPKAPK3 | 0.62979895 |
| 78 | ADRBK1 | 0.62596780 |
| 79 | CSNK1G2 | 0.62192162 |
| 80 | ARAF | 0.62117861 |
| 81 | WNK3 | 0.61192128 |
| 82 | TTK | 0.60958206 |
| 83 | MST1R | 0.60803451 |
| 84 | STK39 | 0.60329658 |
| 85 | CAMKK2 | 0.60171175 |
| 86 | BRSK1 | 0.58115927 |
| 87 | EIF2AK2 | 0.57310705 |
| 88 | EPHA4 | 0.54700416 |
| 89 | ATR | 0.54650662 |
| 90 | TXK | 0.52247604 |
| 91 | AURKA | 0.51979136 |
| 92 | RPS6KA5 | 0.51891971 |
| 93 | MAPKAPK5 | 0.50923218 |
| 94 | MAP3K5 | 0.50408364 |
| 95 | CAMK2A | 0.49933889 |
| 96 | PBK | 0.49613861 |
| 97 | PIM2 | 0.48931605 |
| 98 | CHEK2 | 0.48784012 |
| 99 | TAOK3 | 0.47668847 |
| 100 | ABL2 | 0.47309368 |
| 101 | PRKCG | 0.45586473 |
| 102 | PLK3 | 0.45024642 |
| 103 | PLK4 | 0.44894440 |
| 104 | MAP2K6 | 0.44643373 |
| 105 | PIK3CG | 0.44585386 |
| 106 | PDPK1 | 0.42521706 |
| 107 | PRKACA | 0.42107602 |
| 108 | MAP3K3 | 0.42058722 |
| 109 | MAP2K3 | 0.41576148 |
| 110 | MAPK11 | 0.41321178 |
| 111 | PRKAA1 | 0.39993045 |
| 112 | AURKB | 0.38579648 |
| 113 | CAMK2B | 0.38497946 |
| 114 | PLK1 | 0.38114099 |
| 115 | CSNK1A1 | 0.36577524 |
| 116 | PRKACB | 0.36231150 |
| 117 | PAK3 | 0.32870208 |
| 118 | PRKACG | 0.32664178 |
| 119 | TEC | 0.32472788 |
| 120 | PDK1 | 0.32205252 |
| 121 | NTRK3 | 0.32165900 |
| 122 | DAPK2 | 0.31984630 |
| 123 | PRKAA2 | 0.30679941 |
| 124 | ROCK1 | 0.30535868 |
| 125 | VRK1 | 0.30494605 |
| 126 | STK3 | 0.29979735 |
| 127 | DYRK2 | 0.29819381 |
| 128 | ERBB4 | 0.29731593 |
| 129 | IKBKB | 0.29616132 |
| 130 | MST4 | 0.28772768 |
| 131 | CSNK2A1 | 0.27754053 |
| 132 | INSRR | 0.26536579 |
| 133 | TESK1 | 0.25986520 |
| 134 | BCR | 0.24604136 |
| 135 | MAP2K1 | 0.24213320 |
| 136 | STK4 | 0.23812107 |
| 137 | GRK5 | 0.23627422 |
| 138 | PRKCE | 0.23158351 |
| 139 | CSNK2A2 | 0.22121798 |
| 140 | RPS6KC1 | 0.22111692 |
| 141 | RPS6KL1 | 0.22111692 |
| 142 | PTK2B | 0.22030048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.25322457 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.95517986 |
| 3 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.72693641 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.35909387 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.27392012 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23974353 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99728365 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.73714104 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71596276 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.66360349 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.59464740 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30957730 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.29131753 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.27735721 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.20806634 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.14237029 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13936740 |
| 18 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.07879616 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01635393 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85677624 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81041652 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.76954105 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59519438 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58742650 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58380020 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56757816 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.56533342 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47342609 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.45911022 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41730207 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40801317 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39737076 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36409105 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34383912 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30586270 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25770873 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.25043534 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21176808 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12205518 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08918188 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.07502596 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01722887 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00651265 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98709939 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96470528 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94195577 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93112253 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91881098 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90362664 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90320153 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87639357 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85136479 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.83883875 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83483112 |
| 55 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.83291282 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.82348420 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82127703 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79825166 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79341469 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78600493 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 0.78340477 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76125985 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70382739 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69908517 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69237574 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67383967 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67021643 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65446626 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65332082 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64768988 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64273190 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62053566 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61633516 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60674819 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59214803 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57869345 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57271109 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57188811 |
| 79 | Spliceosome_Homo sapiens_hsa03040 | 0.56626724 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54431171 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53248022 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.53057566 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52754349 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52336955 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51574366 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50190245 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45136833 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44364899 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44214686 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40745392 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.40632800 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38750767 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38345570 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37718772 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37316766 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35685712 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35249688 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34767668 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34731457 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.33845044 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.33045494 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32919874 |
| 103 | Taste transduction_Homo sapiens_hsa04742 | 0.31348879 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.30058807 |
| 105 | Protein export_Homo sapiens_hsa03060 | 0.29075653 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28239607 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27471492 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27168143 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.26613021 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26371188 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26116432 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25393614 |
| 113 | DNA replication_Homo sapiens_hsa03030 | 0.22493368 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.15044365 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.13811554 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10951996 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.10895119 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10112256 |
| 119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.09664662 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.09392601 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08608340 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.07188614 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.06521479 |
| 124 | RNA transport_Homo sapiens_hsa03013 | 0.06303992 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.05015638 |

